123 related articles for article (PubMed ID: 4382059)
41. Antitumor activity and bone marrow toxicity of aminoglucose mustard anticancer agents in mice.
Cantrell JE; Green D; Schein PS
Cancer Res; 1986 May; 46(5):2340-3. PubMed ID: 2938728
[TBL] [Abstract][Full Text] [Related]
42. Comparative study of mannitol mustard, cyclophosphamide, and nitrogen mustard in malignant lymphomas.
LASZLO J; GRIZZLE J; JONSSON U; RUNDLES RW
Cancer Chemother Rep; 1962 Feb; 16():247-50. PubMed ID: 14462650
[No Abstract] [Full Text] [Related]
43. The effects of cyclophosphamide and nor-nitrogen mustard administration to one-day-old mice.
Short R; Gibson J
Experientia; 1971 Jul; 27(7):805-6. PubMed ID: 5139499
[No Abstract] [Full Text] [Related]
44. Dependence on treatment time of melphalan resistance and DNA cross-linking in human melanoma cell lines.
Parsons PG
Cancer Res; 1984 Jul; 44(7):2773-8. PubMed ID: 6722805
[TBL] [Abstract][Full Text] [Related]
45. NITROGEN MUSTARD-RESISTANT YOSHIDA SARCOMA AND CROSS-RESISTANCE STUDIES.
UJHAZY V; WINKLER A
Neoplasma; 1965; 12():11-4. PubMed ID: 14278323
[No Abstract] [Full Text] [Related]
46. [Effect of toxic doses of antineoplastic agents on cellular composition of porous connective tissue of mice].
Rozenberg IB
Farmakol Toksikol; 1970; 33(2):212-6. PubMed ID: 5425631
[No Abstract] [Full Text] [Related]
47. INTERACTION BETWEEN 5-HYDROXYTRYPTAMINE AND ANTITUMOURAL DRUGS.
PALMA V; REYERS-DEGLIINNOCENTI I; GARATTINI S
J Pharm Pharmacol; 1964 Nov; 16():770-1. PubMed ID: 14241150
[No Abstract] [Full Text] [Related]
48. A comparative study with three alkylating agents: mechlorethamine, cyclophosphamide, and uracil mustard.
GOLD GL; SALVIN LG; SHNIDER BI
Cancer Chemother Rep; 1962 Feb; 16():417-9. PubMed ID: 13899670
[No Abstract] [Full Text] [Related]
49. Toxicity of the alkylating agent bendamustin.
Horn U; Härtl A; Güttner J; Hoffmann H
Arch Toxicol Suppl; 1985; 8():504-6. PubMed ID: 3868382
[TBL] [Abstract][Full Text] [Related]
50. Therapeutic journery of nitrogen mustard as alkylating anticancer agents: Historic to future perspectives.
Singh RK; Kumar S; Prasad DN; Bhardwaj TR
Eur J Med Chem; 2018 May; 151():401-433. PubMed ID: 29649739
[TBL] [Abstract][Full Text] [Related]
51. Specificity and kinetics of interstrand and intrastrand bifunctional alkylation by nitrogen mustards at a G-G-C sequence.
Bauer GB; Povirk LF
Nucleic Acids Res; 1997 Mar; 25(6):1211-8. PubMed ID: 9092631
[TBL] [Abstract][Full Text] [Related]
52. Effect of oxygen tension on the sensitivity of normal and tumor tissues to alkylating agents.
BACK N; AMBRUS JL
J Natl Cancer Inst; 1963 Jan; 30():17-29. PubMed ID: 13965953
[No Abstract] [Full Text] [Related]
53. [EVALUATION OF THE CURRENT THERAPEUTIC TRENDS IN HODGKIN'S DISEASE. CRITICAL REVIEW AND CASUISTIC CONTRIBUTION].
TAGLIORETTI D; TESTERO S; TISO R; ERIDANI S
Arch Patol Clin Med; 1963 Aug; 40():3-32. PubMed ID: 14058830
[No Abstract] [Full Text] [Related]
54. COMPARATIVE RESPONSE OF A SPECTRUM OF TRANSPLANTABLE RAT NEOPLASMS TO NITROGEN MUSTARD, TRIETHYLENEMELAMINE, AND A GROUP OF BENZALDEHYDE MUSTARD DERIVATIVES.
DUNNING WF; CURTIS MR
Cancer Chemother Rep; 1964 Mar; 36():5-19. PubMed ID: 14152277
[No Abstract] [Full Text] [Related]
55. THE TREATMENT OF MALIGNANT DISEASE BY REGIONAL CHEMOTHERAPY.
JOHNSTON ID
Ulster Med J; 1963 Dec; 32(2):151-9. PubMed ID: 14105942
[No Abstract] [Full Text] [Related]
56. The effect of antihistamines in decreasing the toxicity of alkylating agents.
Rochlin DB; Goepfert H; Damnavits J
Surg Gynecol Obstet; 1967 Apr; 124(4):771-7. PubMed ID: 4381235
[No Abstract] [Full Text] [Related]
57. Covalent binding of nitrogen mustards to the cysteine-34 residue in human serum albumin.
Noort D; Hulst AG; Jansen R
Arch Toxicol; 2002 Mar; 76(2):83-8. PubMed ID: 11914777
[TBL] [Abstract][Full Text] [Related]
58. [Effect of serotonin on the antineoplastic activity and toxicity of sarcolysin and dopan].
Mal'tseva LF
Farmakol Toksikol; 1966; 29(6):698-701. PubMed ID: 6000367
[No Abstract] [Full Text] [Related]
59. Survival of hematopoietic and lymphoma colony-forming cells in vivo following the administration of a variety of alkylating agents.
Valeriote FA; Tolen SJ
Cancer Res; 1972 Mar; 32(3):470-6. PubMed ID: 4621955
[No Abstract] [Full Text] [Related]
60. Chemotherapy of induced skin tumors in mice.
Sugiura K
Gan; 1968 Oct; 59(5):367-76. PubMed ID: 4179170
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
